Received Mar 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | Xx33p | — |
Bexsero dose was given to a 14-month-old patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 14-month-old female patient who received Men B NVS (Bexsero) (batch number Xx33p, expiry date 31-JAN-2026) for prophylaxis. On 03-MAR-2025, the patient received Bexsero. On 03-MAR-2025, an unknown time after receiving Bexsero, the patient experienced inappropriate age at vaccine administration (Verbatim: Bexsero dose was given to a 14-month-old patient). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 03-MAR-2025 Medical assistant calls to reporta Bexsero dose was given to a 14-month-old patient, which led to Inappropriate age at vaccine administration. The reporter consented to follow up via email.